Basic Information
| LncRNA/CircRNA Name | CTC |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | papillary thyroid cancer |
| ICD-0-3 | NA |
| Methods | qRT-PCR, Western blot |
| Sample | PTC tissues,cell lines |
| Expression Pattern | down-regulated |
| Function Description | CTC functions as a competing endogenous RNA to inhibit the progression and chemoresistance of PTC cells, and identifes CTC serve as a potential therapeutic agent to suppress PTC progression. |
| Pubmed ID | 32165673 |
| Year | 2020 |
| Title | Long Noncoding RNA CTC Inhibits Proliferation and Invasion by Targeting miR-146 to Regulate KIT in Papillary Thyroid Carcinoma |
External Links
| Links for CTC | GenBank HGNC NONCODE |
| Links for papillary thyroid cancer | OMIM COSMIC |